V-Wave's Interatrial Shunt Receives FDA Breakthrough Device Designation for Heart Failure
August 15, 2019—V-Wave Ltd., a privately held Israel-based company developing novel implantable interatrial shunt devices, announced that the FDA has granted Breakthrough Device designation for its interatrial shunt for heart failure.
V-Wave's minimally invasive, implanted interatrial shunt is being evaluated in the pivotal RELIEVE-HF investigational device exemption trial. The global, randomized, controlled, double-blinded study. It is enrolling 500 patients who have advanced heart failure with preserved or reduced left ventricular ejection fraction who remain symptomatic despite the use of guideline-directed medical and device therapies.
The V-Wave interatrial shunt system is under clinical investigation and is not available for sale in the United States or other countries, cautioned the company.
In its announcement, the company advised that the FDA's breakthrough device designation is granted to devices that have the potential to offer a more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases. The program aims to provide patients and health care providers with more timely access to medical devices by speeding their development, assessment, and review, including prioritized review all the way through market approval.
The company additionally noted that the Centers for Medicare & Medicaid Services has announced that it is developing a means to expedite reimbursement pathways and provide increased payments for medical devices designated as a breakthrough.
advertisement
Featured Video
Conquer the Calcium.
Deliver the Stent.
Sponsored by Cardiovascular Systems Inc.
Related Articles
Top 5 Articles From August 2019
Large-Bore Access Site Management
State-of-the-art closure techniques for large-bore access.
By Amir Kaki, MD; and M. Chadi Alraies, MD
A Tutorial on Ultrasound-Guided Access
Mastering the ultrasound-guided access technique for cardiac and noncardiac interventions can reduce access-related complications and improve outcomes.
By Maarten P. van Wiechen, MD; and Nicolas M. Van Mieghem, MD, PhD, FACC, FESC
How to Close a PFO With ICE Guidance
A guide to understanding intracardiac echocardiography for PFO closure, including available technologies, proper techniques, and potential benefits and limitations.
By Mohamad Alkhouli, MD
Update on Left Atrial Appendage Occlusion
An overview of innovative preprocedural and intraprocedural imaging techniques, trial data, and current LAAO devices and devices in development.
By Saurabh Sanon, MD; and D. Scott Lim, MD
Radial Compression Devices Used After Cardiovascular Interventions
Discussing the design and function of radial artery compression technologies used for a safe closure of radial access after percutaneous cardiovascular intervention.
By Francesco Costa, MD, PhD, FESC; and Renato Scalise, MD
Top 5 from EVToday's Current Issue
What’s New in Y-90?
Technical and procedural innovations in Y-90 radioembolization including existing and investigational next-generation technologies.
By Robert Abraham, MD, FRCPC, FSIR; Robert Lewandowski, MD, FSIR; Ripal T. Gandhi, MD, FSIR, FSVM; and David M. Liu, MD, FRCPC, FSIR
Transradial Access for Hepatic Oncologic Interventions
Considerations for choosing the right access equipment.
By Darren Klass, MBChB, MD, MRCS, FCRC, FRCPC; Anastasia Hadjivassiliou, MBBS, FRCR, FRCPC; and John Chung, MD, FRCPC
Contemporary Management of Pancreatic Cancer
An update on state-of-the-art minimally invasive therapies, including recent advances in surgery, radiation therapy, ablative options, and endovascular therapies.
By Ripal T. Gandhi, MD, FSIR, FSVM; Horacio Asbun, MD; Michael Chuong, MD; Filipe Kunzler, MD; and Govindarajan Narayanan, MD
Is It Time to End the Therapeutic Nihilism Toward Treating VTE in Cancer Patients?
Cases highlighting the potential for early benefit and improved quality of life and function associated with the use of FlowTriever and ClotTriever Systems in patients with cancer and VTE.
With Sirish A. Kishore, MD; and William C. Dillon, MD, FACC
Top Tips in Interventional Oncology
Clinical and technical insights into treating hepatocellular carcinoma, cholangiocarcinoma, renal cell carcinoma, lung cancer, bone cancer, and in the palliative care setting.
